Anti-acne Cosmetics Market to Reach US$ 10.90 Bn by 2030

The global Anti-acne Cosmetics market size is expected to be worth around US$ 10.90 billion by 2030, according to a new report by Vision Research Reports.

The global Anti-acne Cosmetics market size was valued at US$ 5.47 billion in 2020 and is anticipated to grow at a CAGR of 10.1% during forecast period 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39047

Growth Factors

The high psychological burden associated with acne, especially among women, is expected to be the key growth-driving factor for the market. Moreover, the easy availability of various products to treat acne is anticipated to support the market growth. According to the American Academy of Dermatology, it is one of the common skin disorders in the U.S., affecting approximately 50 million individuals every year, with nearly 85% of individuals between the age group of 12 and 24 years having minor acne. Thus, a high prevalence of this skin disorder is also anticipated to fuel the product demand, thereby augmenting the market growth.

According to a study conducted by SkinStore, an average American woman uses nearly 16 skincare products per day and spends approximately USD 8 each day on facial cosmetics products. Such beauty regimes are also anticipated to propel market growth.

Report Coverage

Report Scope Details
Market Size US$ 10.90 billion by 2030
Growth Rate CAGR of 10.1% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Product type, Gender, End use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned PCA; Obaji; PHYTOMER; Skin Medica; Skin Better Science; Colorescience; Sente; Jan Marini Skin Research; Revision Skincare; The BeautyHealth Company; Glow Biotics; Perricone MD

By Product Type Analysis

On the basis of product, the market is divided into masks, creams & lotions, cleansers & toners, and others. The creams & lotions segment accounted for the maximum share of more than 40% in 2020 owing to the high demand by both men and women.

The others segment include products, such as face washes, gels, serums, and essential oils. The others segment is anticipated to grow at the fastest CAGR during the forecast period due to the compatibility of these products with various skin types and better skin absorption of these products.

By Gender Analysis

The women segment dominated the market in 2020 with a share of over 52%. The segment is expected to expand further at the fastest CAGR over the forecast period.

According to a survey, 62.2% of pre-menopausal women reported worsening of acne during the menstrual cycle. The men segment held a substantial share in 2020.

By End-use Analysis

The Medspa segment accounted for the highest revenue share of more than 62.5% in 2020. The segment is also anticipated to register the fastest CAGR over the forecast period.

The millennial population is the largest target demographic for medical-grade skincare brands. According to the American Spa Association, the revenue of the Medspa industry in the U.S has witnessed a double-digit growth since 2010, and the majority of the Medspa patients were between the ages of 35-54 years.

The number of dermatology clinics is also on the rise globally due to the increasing incidences of skin cancer and lifestyle-related skin conditions, such as acne, atopic dermatitis, and hyperpigmentation.

By Regional Analysis

Asia Pacific dominated the market in 2020 with a revenue share of more than 39% and is estimated to witness lucrative growth over the forecast period. Asia Pacific is the largest potential export market for U.S.-based products owing to over 3 billion potential consumers of anti-acne cosmetic products.

Australia, Japan, and South Korea, are some of the largest consumers of well-established U.S.-based products. In addition, Vietnam, Malaysia, and Indonesia are a few other regions expected to witness the demand for these products in the forecast period.

Key Players

  • PCA
  • Obaji
  • PHYTOMER
  • Skin Medica
  • Skin Better Science
  • Colorescience
  • Sente
  • Jan Marini Skin Research
  • Revision Skincare
  • The BeautyHealth Company
  • Glow Biotics
  • Perricone MD

Market Segmentation

  • By Product Type
    • Mask
    • Creams & Lotions
    • Cleansers & Toners
    • Others
  • By Gender
    • Women
    • Men
  • By End-use
    • Dermatology Clinics
    • Medspa
  • Region
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
    • Latin America
      • Brazil
      • Mexico
    • Middle East & Africa
      • South Africa
      • Saudi Arabia

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Anti-acne Cosmetics Market, By Capacitor

7.1.  Anti-acne Cosmetics Market, by Capacitor, 2021-2030

7.1.1.    Mask

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Creams & Lotions

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Cleansers & Toners

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Others

7.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Anti-acne Cosmetics Market, By Gender

8.1.  Anti-acne Cosmetics Market, by Gender, 2021-2030

8.1.1.    Women

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Men

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Anti-acne Cosmetics Market, By End User

9.1.  Anti-acne Cosmetics Market, by End User, 2021-2030

9.1.1.    Dermatology Clinics

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Medspa

9.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Anti-acne Cosmetics Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Capacitor (2017-2030)

10.1.2.  Market Revenue and Forecast, by Gender (2017-2030)

10.1.3.  Market Revenue and Forecast, by End User (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Gender (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Gender (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Capacitor (2017-2030)

10.2.2.  Market Revenue and Forecast, by Gender (2017-2030)

10.2.3.  Market Revenue and Forecast, by End User (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Gender (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Gender (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Gender (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Gender (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Capacitor (2017-2030)

10.3.2.  Market Revenue and Forecast, by Gender (2017-2030)

10.3.3.  Market Revenue and Forecast, by End User (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Gender (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Gender (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Gender (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Gender (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Capacitor (2017-2030)

10.4.2.  Market Revenue and Forecast, by Gender (2017-2030)

10.4.3.  Market Revenue and Forecast, by End User (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Gender (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Gender (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Gender (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Gender (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Capacitor (2017-2030)

10.5.2.  Market Revenue and Forecast, by Gender (2017-2030)

10.5.3.  Market Revenue and Forecast, by End User (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Gender (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Capacitor (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Gender (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by End User (2017-2030)

Chapter 11.  Company Profiles

11.1.              PCA

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Obaji

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              PHYTOMER

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Skin Medica

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Skin Better Science

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Colorescience

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Sente

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Jan Marini Skin Research

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Revision Skincare

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           The BeautyHealth Company

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39047

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Leave a Reply

Your email address will not be published. Required fields are marked *